Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 698 16 409.1 |
96 | EP file number | EAKZ | 98 12 3878.5 |
97 | EP publication number | EPN | 926158 |
54 | Designation/title | TI | Kristallines Parathyroidhormon |
51 | IPC main class | ICM (ICMV) | C07K 14/635 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 1/14 (2006.01) |
22 | DE application date | DAT | Dec 16, 1998 |
96 | EP application date | EAT | Dec 16, 1998 |
43 | Date of first publication | OT | Jun 30, 1999 |
| Date of publication of grant | PET | Jul 16, 2003 |
71/73 | Applicant/owner | INH | Eli Lilly and Co., Indianapolis, Ind., US |
72 | Inventor | IN | Zhang, Faming, Carmel, US |
74 | Representative | VTR | Spott, Weinmiller & Böhm, 80336 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000069816409T2 Searchable text:
DE000069816409T2 |
| Address for service | | Patentanwälte Spott, Weinmiller & Böhm, 80336 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 69875 Dec 18, 1997
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
43 | Date of first publication | EVT | Jun 30, 1999 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 25, 2015 (Show all update days)(Hide all update days)- Mar 25, 2015; Jan 21, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|